As a conservative treatment of compression fractures, absolute bed rest (ABR) for a certain period has been recommended, but no guideline on the period has yet been established. Considering that a long ABR period may adversely affect patients, the difference in prognosis according to the ABR period was investigated in this study.
A prospective study was conducted who were diagnosed with compression fracture. Groups A and B were put on ABR (one week for group A and two weeks for group B). X-ray images at baseline, 1, 2, 4, and 8 weeks were obtained from both groups, for assessment purposes.
The compression rates of both groups were no significant difference at baseline, 1, 2, 4, and 8 weeks. The conditions of 25.9% and 21.2% of the subjects deteriorated in groups A and B, showing no significant difference. Between the groups of age and bone mineral densities (BMD), no significant difference was observed in the incidence of deterioration. In terms of complications development including constipation and other Gastrointestinal problems, voiding difficulty, etc., group A reported 57.4%, and group B, 84.8%, showing a significant difference (p-value=0.001).
No significant difference in the conservative period was observed between the groups. Group B, however, reported a higher complications development rate than group A. Therefore, a short ABR period may be helpful in the early stage of conservative treatment.
Compression fractures are usually caused by osteoporosis, severe trauma, infection, and neoplasm
A prospective study was conducted that targeted 232 patients who were hospitalized in the Department of Neurosurgery and who were diagnosed with compression fracture from January 2010 to September 2012. Group A was put on ABR for one week, and Group B, for two weeks. Among the patients in the two groups, those whose follow-up were interrupted, whose fractures were caused by tumors, and who underwent early-stage surgical treatments were excluded from this study. The total of 120 patients who were finally selected for this study, 54 Group A patients were put on one-week ABR, and 66 Group B patients, on two-week ABR.
The groups were compared according to their ABR periods, which were one week for Group A and two weeks for Group B. The two groups were selected randomly. In each group, the subjects' ages, gender, lengths of hospital day, bone mineral density (BMD) and fracture level, visual analog scale (VAS) scores and compression rate in each ABR period were investigated. The compression rate was calculated as follows: 100-[b/(a+c/2)]×100, wherein "a" and "c" represent the normal vertebral bodies that were one level higher and lower than the compression-fractured vertebral body, respectively, and "b" represents the height of the compression-fractured vertebral body
Statistical analysis was performed using SPSS statistic software ver. 19.0.0 (SPSS Inc, Chicago, IL). Chi-square test, Fisher's exact test, Independent Samples T-test were used. A P-value of less than 0.05 was considered statistically significant.
Group A had a mean age of 69.7±12.9 years, a mean BMD of -3.5±1.3, 15 male and 39 female patients, and a mean length of hospital day of 14.2±7.3 day, On the other hand Group B had a mean age of 66.1±14.4 years, a mean BMD of -3.5±1.3, 18 male and 48 female patients, and a mean length of hospital day of 25.9±9.5 days (
Three male subjects reported deteriorations in Group A and the same number in Group B (p-value=1.0), and 11 females each in Groups A and B (p-value=0.602).
Among the subjects aged 75 years or older, 10 in Group A and slightly fewer, seven, in Group B had deteriorated conditions (p-value=0.216); and among the subjects aged less than 75 years, four in Group A and seven in Group B (p-value = 0.752). No significant differences in the ages and the ABR periods of the two groups were observed. Three subjects reported -3.0 or higher BMD deterioration in Group A, and two in Group B (p-value=0.656). In Group A, 11 subjects reported deteriorations with -3.1 or less BMD; and in Group B, 12 subjects (p-value=0.762). The difference between the groups in the rates of their compression fracture deterioration according to their ABR period and BMD was not statistically significant (
A total of 87 subjects reported the development of complications: 31 in Group A and 56 in Group B. Thus, there were more complications in the longer ABR group (p-value=0.001). The most common complication was gastrointestinal (GI) problems such as constipation, heartburn and nausea, followed by voiding difficulty (
Percutaneous vertebroplasty and balloon kyphoplasty have been studied as surgical treatments for compression fractures
The treatment goals for compression fracture include pain relief, vertebral stability, rehabilitation and osteoporosis improvement
In the study conducted by Peter Vorlat et al.
In terms of the compression rate of the groups, no statistically significant difference was observed in the X-ray images at the baseline and after one, two, four and eight weeks. In both groups, there were more female patients than male patients, as in most relevant studies
During the hospital stay, block was conducted for eight subjects (14%) in Group A and 13 subjects (19.7%) in Group B due to persistent pain (p-value=0.484). The mean lengths of time before the block implementation were 11.5±4.5 days in Group A and almost the same, 16.3±11.0 days, in Group B (p-value=0.171). In the study on gray ramus communicans nerve block in compression fracture patients conducted by Tae et al.
For the complications of bed rest, muscle weakness, systemic inflammation, atelectasis, metabolic change, microvascular dysfunction, thromboembolic diseases, joint contracture, and skin ulcer were described
In this study, no serious complications were observed during the short one- and two-week bed rest periods. The most common complications in Group A included GI problems such as constipation and diarrhea, followed by voiding difficulty and dizziness; and in Group B, constipation, followed by other GI problems, cough and voiding difficulty. Moreover, the incidences of constipation (p-value=0.005), GI problems (p-value=0.003) and cough (p-value=0.008) significantly increased with a longer bed rest. Most of the complications were controlled with medications, and most of the symptoms disappeared through ambulation and rehabilitation.
However, in this study, the groups of patients were divided randomly, so the comparison of the two groups according to the degree of their compression fracture was insufficient. When treating patients, it is unreasonable to apply one-week ABR unconditionally and uniformly to the group of patients with a serious compression rate, and more detailed studies on this are needed.
In this study, no statistically significant difference in the incidence of clinical deterioration was observed between the one- and two-week absolute best rest (ABR) groups. No significant differences were observed either in the results of the bed rest periods in terms of age and bone density. By contrast, the incidences of complications and discomfort increased in the longer-ABR-period group. In conclusion, the short term bed rest period is recommended in compression fracture patients to reduce the treatment period and inconvenience of the patients.
Levels of compression fracture.
Base information of patients in both groups
Group A | Group B | p-value | ||
---|---|---|---|---|
Patients (n) | 54 | 66 | ||
Age (years) | 69.7±12.9 | 66.1±14.4 | 0.161 | |
Sex | Male (n) | 15(27.8%) | 18(27.3%) | 0.951 |
Female (n) | 39(72.2%) | 48(72.7%) | 0.951 | |
Hospital days (days) | 14.2±7.3 | 25.9±9.5 | <0.001 | |
BMD (SD) | -3.5±1.3 | -3.5±1.3 | 0.983 |
n: number of patients; BMD: bone mineral density; Group A: absolute bed rest 1 week; Group B: absolute bed rest 2 weeks group
SD: standard deviation
Compression rate after absolute bed rest in both groups
Group A | Group B | p-value | |
---|---|---|---|
Compression rate initial (%) | 21.1±10.7 | 21.9±13.6 | 0.701 |
1st week (%) | 22.3±10.1 | 23.4±13.1 | 0.610 |
2nd week (%) | 22.7±10.9 | 23.9±13.3 | 0.328 |
4th week (%) | 27.0±11.1 | 27.8±14.2 | 0.259 |
8th week (%) | 28.6±9.4 | 29.3±15.2 | 0.880 |
Group A: absolute bed rest 1 week; Group B: absolute bed rest 2 weeks group
Complications and deteriorations in both gruops
Group A | Group B | p-value | |
---|---|---|---|
Deteriorations (n) | 14(25.9%) | 14(21.2%) | 0.544 |
Complications (n) | 31(57.4%) | 56(84.8%) | 0.001 |
Nerve block (n) | 8(14%) | 13(19.7%) | 0.484 |
Day to block(days) | 11.5±4.5 | 16.3±11.0 | 0.171 |
n: number of patients
VAS score after absolute bed rest in both groups
Group A | Group B | p-value | |
---|---|---|---|
VAS score initial | 6.3±0.9 | 6.3±1.3 | 0.986 |
1st week (%) | 2.6±1.0 | 2.7±0.8 | 0.495 |
2nd week (%) | 2.3±0.8 | 2.3±0.8 | 0.515 |
4th week (%) | 2.1±0.9 | 2.2±0.9 | 0.429 |
8th week (%) | 2.2±1.4 | 2.3±1.1 | 0.553 |
VAS: visual analog scales
Deteriorations after absolute bed rest according to sex, age, BMD
Group A | Group B | p-value | ||
---|---|---|---|---|
Deteriorations (n) | 14(25.9%) | 14(21.2%) | 0.544 | |
Sex | Male (n) | 3(5.6%) | 3(4.5%) | 1.0 |
Female (n) | 11(20.3%) | 11(16.7%) | 0.602 | |
Age | ≥75(years) | 10(18.5%) | 7(10.6%) | 0.216 |
<75 (years) | 4(7.4%) | 7(10.6%) | 0.752 | |
BMD | ≥-3.0 (SD) | 3(5.6%) | 2(3.0%) | 0.656 |
≤-3.1 (SD) | 11(20.3%) | 12(18.2%) | 0.762 |
n: number of patients, BMD: bone mineral density; Group A: absolute bed rest 1 week; Group B: absolute bed rest 2 weeks group
SD: standard deviation
Complications in the both groups
Group A | Group B | p-value | |
---|---|---|---|
Total Pts with Cx (n) | 31(57.4%) | 56(84.8%) | 0.001 |
Constipation (n) | 18(33.3%) | 39(59.1%) | 0.005 |
GI trouble (n) | 5(9.3%) | 21(31.8%) | 0.003 |
Voiding difficulty (n) | 4(7.4%) | 6(9.1%) | 1.0 |
UTI (n) | 1(1.9%) | 2(3.0%) | 1.0 |
Dizziness (n) | 3(5.6%) | 3(4.5%) | 1.0 |
Dermatitis (n) | 1(1.9%) | 1(1.5%) | 1.0 |
Cough (n) | 0(0%) | 8(12.1%) | 0.008 |
Pts: patients; Cx: Complication; n: number of patients
GI: gastrointestinal; UTI: urinary tract infection; Group A: absolute bed rest 1 week; Group B: absolute bed rest 2 weeks group